NHSBSA prescription data drives clinical research to enhance anaphylaxis management and patient safety14 January 2026Two new research papers show how NHS Business Services Authority (NHSBSA) ...
Certain people risk severe or life-threatening reactions if they consume these products, according to an official alert.
A coroner said that the 55-year-old’s death was ‘pursuant to developing an anaphylactic reaction to a bee sting on his left ...
SAN DIEGO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to ...
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives ...
The FDA has announced a Class II recall for hummus sold in East Coast specialty stores, indicating the products could cause ...
Roth Capital Markets analyst Kyle Bauser has reiterated a Buy rating and a 12-month price target of $30.00 on ARS ...
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA ...
A pioneering education initiative from The Natasha Allergy Research Foundation is helping transform how education settings ...
Call for potentially life-saving EpiPens to become a part of school equipment in Pembrokeshire will be considered ...
San Diego, USA-based ARS Pharmaceuticals (Nasdaq: SPRY) has announced that China’s National Medical Products Administration (NMPA) has granted approval for neffy 2mg (epinephrine nasal spray) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback